Ranomics provides high-throughput screening services and custom DNA variant libraries to accelerate the development of biologic products in the biotechnology sector. By utilizing advanced techniques in protein and cell engineering, the company enables partners to enhance product efficacy and streamline research workflows.
Funding
$1.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Biotechnology and pharmaceutical companies face challenges in efficiently developing biologic products due to the complexities of protein and cell engineering. Traditional methods for optimizing these products can be time-consuming and resource-intensive.
Solution
Ranomics provides high-throughput screening services and custom DNA variant libraries to accelerate the development of biologic products. They offer expertise in DNA synthesis, variant libraries, protein engineering, cell engineering, and genome engineering, enabling partners to develop cell, protein, and biologic products more effectively. Ranomics' services facilitate the design, construction, and optimization of biological products by identifying novel and functionally important variants. Their cell-based screening assays enable rapid optimization of assets in research and product development programs.
Target Audience
Ranomics primarily serves biotechnology and pharmaceutical companies seeking to optimize and develop novel biologic products.
Features
- Custom DNA variant libraries including combinatorial, site-saturation, gene shuffle, and promoter sequence libraries
- Protein engineering services such as directed evolution, deep mutational scanning, and high-throughput protein expression
- Antibody engineering services including affinity maturation, antibody characterization, and cell-based antibody binding assays
- Gene and cell therapy solutions including AAV vector and promoter optimization, and CRISPR-Cas protein engineering
- Industrial synthetic biology solutions for enzyme stability enhancement, metabolic engineering, and strain development
- Custom cell-based assays including droplet-based NGS screening, mRNA expression studies, and flow cytometry analysis
- Yeast and mammalian cell display platforms
- VERG high-throughput screening platform